CI-135

CI-135 · Hrain Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CI-135, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Human CI-135 (FLT3) Targeted CAR-T Cells Injection for Subjects with Relapsed/Refractory Acute Myeloid Leukemia [EARLY_Phase 1]

See pricing